Methylation status of CpG sites in the MCP-1 promoter is correlated to serum MCP-1 in type 2 diabetes

Journal of Endocrinological Investigation

Volumn 35, Issue 6, 2012, Pages 585-589

  Liu, Z H ^a,b   Chen, L L ^a   Deng, X L ^a   Song, H J ^a   Liao, Y F ^a   Zeng, T S ^a   Zheng, J ^a   Li, H Q ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b YANGTZE UNIVERSITY   (China)

Author keywords

Epigenetics; MCP 1; Methylation; Type 2 diabetes

Indexed keywords

GENOMIC DNA; GLUCOSE; HEMOGLOBIN A1C; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CPG ISLAND; DIET RESTRICTION; DNA ISOLATION; DNA METHYLATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; SERUM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CPG ISLANDS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TRIGLYCERIDES;

EID: 84863942908     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7981     Document Type: Article

References (32)

1. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88: 1121-7.
2. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398: 718-23.
3. Namiki M, Kawashima S, Yamashita T, et al. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002, 22: 115-20. (Pubitemid 34076241)
4. Esposito K, Nappo F, Giugliano F, et al. Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care 2003, 26: 1647. (Pubitemid 36929221)
5. Piemonti L, Calori G, Lattuada G, et al. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals. Diabetes Care 2009, 32: 2105-10.
6. Li H, Deng X, Li Z, Luo C, Liu J, Wang Y. Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome. J Huazhong Univ Sci Technolog Med Sci 2011, 31: 312-6.
7. Davi G, Tuttolomondo A, Santilli F, et al. CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. J Atheroscler Thromb 2009, 16: 707-13.
8. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997, 272: 31092-9. (Pubitemid 27527558)
9. Simeoni E, Hoffmann MM, Winkelmann BR, et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 2004, 47: 1574-80. (Pubitemid 39371640)
10. Turunen MP, Aavik E, Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 2009, 1790: 886-91.
11. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008, 205: 2409-17.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20: 1183-97.
13. Yu X, Ling W, Mi M. Relationship of impairment induced by intracellular S-adenosylhomocysteine accumulation with DNA methylation in human umbilical vein endothelial cells treated with 3- deazaadenosine. Int J Exp Pathol 2009, 90: 638-48.
14. Nomura S, Shouzu A, Omoto S, et al. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 2000, 121: 437-43.
15. Piemonti L, Calori G, Mercalli A, et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003, 26: 2883-9. (Pubitemid 37205563)
16. McDermott DH, Yang Q, Kathiresan S, et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005, 112: 1113-20. (Pubitemid 41216117)
17. Yuasa S, Maruyama T, Yamamoto Y, et al. MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract 2009, 86: 193-8.
18. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010, 467: 963-6.
19. Yang BT, Dayeh TA, Kirkpatrick CL, et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia 2011, 54: 360-7.
20. Cooper ME, El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res 2010, 107: 1403-13.
21. Baccarelli A, Tarantini L, Wright RO, et al. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics 2010, Apr 1 [Epub ahead of print]; doi: 10.4161/epi.5.3.11377.
22. Reik W, Walter J. Genomic imprinting: Parental influence on the genome. Nat Rev Genet 2001, 2: 21-32. (Pubitemid 33674766)
23. Herder C, Baumert J, Thorand B, et al. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 2006, 49: 921-9.
24. Herder C, Baumert J, Thorand B, et al. Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 2006, 26: 2147-52. (Pubitemid 44253801)
25. de Lemos JA, Morrow DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and longterm clinical outcomes in patients with acute coronary syndromes. Circulation 2003, 107: 690-5. (Pubitemid 36222595)
26. Hoogeveen RC, Morrison A, Boerwinkle E, et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis 2005, 183: 301-7. (Pubitemid 41579281)
27. Lim SO, Gu JM, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008, 135: 2128-40, 2140.e1-8.
28. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998, 78: 547-81. (Pubitemid 28182903)
29. Wachsman JT. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res 1997, 375: 1-8. (Pubitemid 27152196)
30. Kamei Y, Suganami T, Ehara T, et al. Increased expression of DNA methyltransferase 3a in obese adipose tissue: studies with transgenic mice. Obesity (Silver Spring) 2010, 18: 314-21.
31. Jiang Y, Zhang J, Xiong J, et al. Ligands of peroxisome proliferator- activated receptor inhibit homocysteine-induced DNA methylation of inducible nitric oxide synthase gene. Acta Biochim Biophys Sin (Shanghai) 2007, 39: 366-76. (Pubitemid 46792123)
32. Malanovic N, Streith I, Wolinski H, Rechberger G, Kohlwein SD, Tehlivets O. S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis. J Biol Chem 2008, 283: 23989-99.